The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $10.45

Today's change-0.38 -3.51%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $10.45

Today's change-0.38 -3.51%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.

Ironwood Pharmaceuticals Inc crosses below 125-day moving average

Ironwood Pharmaceuticals Inc closed sharply lower Friday, dropping (U.S.)$0.38 or 3.51% to (U.S.)$10.45 and crossing below its 125-day moving average. Over the last five days, shares have lost 3.60% and are down 9.84% for the last year to date. This security has underperformed the S&P 500 by 24.64% during the last year.

Key company metrics

  • Open(U.S.) $10.80
  • Previous close(U.S.) $10.83
  • High(U.S.) $10.85
  • Low(U.S.) $10.43
  • Bid / Ask(U.S.) $8.99 / (U.S.) $0.00
  • YTD % change-9.84%
  • Volume1,398,376
  • Average volume (10-day)2,591,585
  • Average volume (1-month)1,818,083
  • Average volume (3-month)1,577,138
  • 52-week range(U.S.) $7.35 to (U.S.) $14.60
  • Beta1.56
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.00
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue53402829
Total other revenue--------
Total revenue53402829
Gross profit53402029
Total cost of revenue0080
Total operating expense59667057
Selling / general / administrative32303330
Research & development28262927
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)09----
Other operating expenses, total--------
Operating income-6-26-42-28
Interest income (expense), net non-operating-10-10-6-5
Gain (loss) on sale of assets--------
Other--------
Income before tax-14-47-48-33
Income after tax-14-47-48-33
Income tax, total--------
Net income-14-47-48-33
Total adjustments to net income--------
Net income before extra. items-14-47-48-33
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-14-47-48-33
Inc. avail. to common incl. extra. items-14-47-48-33
Diluted net income-14-47-48-33
Dilution adjustment--0----
Diluted weighted average shares143142142141
Diluted EPS excluding extraordinary itemsvalue per share-0.10-0.33-0.34-0.24
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.10-0.27-0.34-0.24